A case of juvenile amyopathic dermatomyositis with anti‐transcription intermediary factor 1‐α antibody showing negative <scp>anti‐TIF1</scp> ‐γ <scp>ELISA</scp> results: Comment on 'Case of pembrolizumab‐induced dermatomyositis with anti‐transcription intermediary factor 1‐γ antibody'

Authors :: Haruka Koizumi
Yoshinao Muro
Satoko Imai
Yuta Yamashita
Mariko Ogawa‐Momohara
Takuya Takeichi
Megumi Murakami
Teruyuki Mitsuma
Masashi Akiyama
Source :: The Journal of Dermatology. 50
Publication Year :: 2022
Publisher :: Wiley, 2022.

Tools